ATE421879T1 - Kleine organische moleküle, die die aktivität von gelatinase a in zellen der augen steigern - Google Patents
Kleine organische moleküle, die die aktivität von gelatinase a in zellen der augen steigernInfo
- Publication number
- ATE421879T1 ATE421879T1 AT03770361T AT03770361T ATE421879T1 AT E421879 T1 ATE421879 T1 AT E421879T1 AT 03770361 T AT03770361 T AT 03770361T AT 03770361 T AT03770361 T AT 03770361T AT E421879 T1 ATE421879 T1 AT E421879T1
- Authority
- AT
- Austria
- Prior art keywords
- organic molecules
- small organic
- activity
- increase
- gelatinase
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 2
- 102000013382 Gelatinases Human genes 0.000 title 1
- 108010026132 Gelatinases Proteins 0.000 title 1
- 102000008887 Membrane-Associated Matrix Metalloproteinases Human genes 0.000 abstract 2
- 108010088571 Membrane-Associated Matrix Metalloproteinases Proteins 0.000 abstract 2
- 102000000424 Matrix Metalloproteinase 2 Human genes 0.000 abstract 1
- 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 abstract 1
- 206010030348 Open-Angle Glaucoma Diseases 0.000 abstract 1
- 230000004888 barrier function Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 201000006366 primary open angle glaucoma Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
- C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
- C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/18—[b, e]-condensed with two six-membered rings
- C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Enzymes And Modification Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/260,448 US7071211B2 (en) | 2002-09-27 | 2002-09-27 | Small organic molecules that increase the activity of gelatinase a in ocular cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE421879T1 true ATE421879T1 (de) | 2009-02-15 |
Family
ID=32041805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03770361T ATE421879T1 (de) | 2002-09-27 | 2003-09-19 | Kleine organische moleküle, die die aktivität von gelatinase a in zellen der augen steigern |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7071211B2 (de) |
| EP (1) | EP1542687B1 (de) |
| JP (1) | JP2006503070A (de) |
| KR (1) | KR20050057581A (de) |
| CN (1) | CN1684682A (de) |
| AT (1) | ATE421879T1 (de) |
| AU (1) | AU2003278842B2 (de) |
| BR (1) | BR0314802A (de) |
| CA (1) | CA2500200A1 (de) |
| DE (1) | DE60326051D1 (de) |
| ES (1) | ES2320440T3 (de) |
| MX (1) | MXPA05003113A (de) |
| PL (1) | PL375046A1 (de) |
| RU (1) | RU2005111964A (de) |
| TW (1) | TW200407158A (de) |
| UA (1) | UA81922C2 (de) |
| WO (1) | WO2004028538A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1730476B (zh) * | 2004-08-06 | 2011-04-06 | 中国医学科学院药物研究所 | 芳胺酮类化合物、其合成方法、含有其的药物组合物及用途 |
| KR100784337B1 (ko) * | 2004-11-12 | 2007-12-13 | 한국생명공학연구원 | 신규한 ｏ-아실옥심 유도체, 그의 제조방법 및 이를유효성분으로 하는 심장순환계 질환의 예방 및 치료용약학 조성물 |
| US20060111388A1 (en) * | 2004-11-19 | 2006-05-25 | University Of North Texas Health Science Center At Fort Worth | Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye |
| WO2007002781A2 (en) * | 2005-06-28 | 2007-01-04 | Bausch & Lomb Incorporated | Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells |
| WO2007005421A2 (en) * | 2005-07-01 | 2007-01-11 | Bausch & Lomb Incorporated | Long lasting alginate dry eye, related methods of manufacture and methods of use |
| US8202226B2 (en) * | 2007-01-23 | 2012-06-19 | Kci Licensing, Inc. | Providing automated or manual guidance on dynamic patient positioning based on measured variables for ventilation control |
| CN103387960B (zh) * | 2013-07-22 | 2015-08-19 | 南京医科大学 | mTOR信号通路激活剂及其在原始卵泡体外激活中的应用 |
| RU2712452C2 (ru) * | 2014-07-02 | 2020-01-29 | Инфлектис Байосайенс | Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий |
| KR20170027737A (ko) * | 2014-07-02 | 2017-03-10 | 인플렉티스 바이오사이언스 | O-알킬-벤질리덴구아니딘 유도체 및 미스폴딩된 단백질의 축적 관련 장애의 치료를 위한 치료 용도 |
| US20180230105A1 (en) | 2017-01-13 | 2018-08-16 | Regents Of The University Of Minnesota | Therapeutic compounds |
| US20210177814A1 (en) | 2018-05-09 | 2021-06-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of guanabenz or derivates thereof for the treatment of type i ifn-dependent pathologies |
| CN113072467B (zh) * | 2021-03-24 | 2022-04-12 | 南方医科大学 | 含取代胍基衍生物及其在制备破骨细胞分化抑制剂上的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3290320A (en) * | 1963-06-12 | 1966-12-06 | Schering Corp | Benzoyl pyridine oximino ethers and methods for their manufacture |
| GB1019120A (en) | 1964-03-18 | 1966-02-02 | Shell Int Research | Novel hydrazine compounds and compositions containing them |
| US3975533A (en) * | 1970-04-29 | 1976-08-17 | Shell Oil Company | Therapeutic agents |
| US3686409A (en) * | 1971-01-27 | 1972-08-22 | Abbott Lab | Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson{40 s disease |
| FR2178304A5 (de) | 1972-03-27 | 1973-11-09 | Rhone Poulenc Sa | |
| GB1458355A (en) * | 1973-01-31 | 1976-12-15 | Agfa Gevaert | Recording processes and materials containing a photo-and or thermo-sensitive amine progenitor |
| GB1554708A (en) * | 1975-09-16 | 1979-10-24 | Agfa Gevaert | Stabilization of free-radical photosensitive materials |
| AT365410B (de) * | 1978-08-31 | 1982-01-11 | Ciba Geigy Ag | Mittel zum schutz von kulturpflanzen vor aggressi-ven herbiziden |
| US4347372A (en) * | 1978-09-01 | 1982-08-31 | Ciba-Geigy Corporation | Benzoxazolyl-glyoxylonitrile-2-oxime ether derivatives |
| US4453974A (en) * | 1980-01-14 | 1984-06-12 | Ciba-Geigy Corporation | Phenyl- and naphthyl-glyoxylonitrile oximino carbamates for the protection of crops against injury by herbicides |
| FR2477537A1 (fr) | 1980-03-07 | 1981-09-11 | Francaise Sucrerie | Nouvelles guanidines acylees, urees et urees substituees, leur procede de fabrication et leur application en tant que medicaments |
| JPS59157637A (ja) * | 1983-02-25 | 1984-09-07 | Fuji Photo Film Co Ltd | 熱現像カラ−感光材料 |
| US5260059A (en) * | 1989-04-14 | 1993-11-09 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University | Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor |
| EP0671911A4 (de) * | 1992-11-25 | 1996-08-21 | Merck & Co Inc | Carboxypeptidyl-derivate als antidegenerative wirkstoffe. |
| US5668133A (en) * | 1992-12-09 | 1997-09-16 | Alcon Laboratories, Inc. | Ophthalmic compositions comprising emedastine and methods for their use |
| US5438056A (en) * | 1993-10-05 | 1995-08-01 | American Home Products Corporation | Heterocyclic oxime carbamates |
| US6566384B1 (en) * | 1996-08-07 | 2003-05-20 | Darwin Discovery Ltd. | Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| CA2271235A1 (en) * | 1996-11-08 | 1998-05-14 | University Of Iowa Research Foundation | Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses |
| EP1047450B1 (de) * | 1997-12-23 | 2002-10-02 | Warner-Lambert Company | Ace hemmer/matrix metalloproteinase hemmer-arzneimittelkombinationen |
| ES2225156T3 (es) * | 1999-06-03 | 2005-03-16 | Maxim Pharmaceuticals, Inc. | Composiciones oftalmicas que contienen histamina y usos de las mismas. |
-
2002
- 2002-09-27 US US10/260,448 patent/US7071211B2/en not_active Expired - Fee Related
-
2003
- 2003-09-19 KR KR1020057005205A patent/KR20050057581A/ko not_active Ceased
- 2003-09-19 EP EP03770361A patent/EP1542687B1/de not_active Expired - Lifetime
- 2003-09-19 JP JP2004540121A patent/JP2006503070A/ja active Pending
- 2003-09-19 AT AT03770361T patent/ATE421879T1/de not_active IP Right Cessation
- 2003-09-19 MX MXPA05003113A patent/MXPA05003113A/es active IP Right Grant
- 2003-09-19 DE DE60326051T patent/DE60326051D1/de not_active Expired - Fee Related
- 2003-09-19 UA UAA200504006A patent/UA81922C2/uk unknown
- 2003-09-19 AU AU2003278842A patent/AU2003278842B2/en not_active Expired - Fee Related
- 2003-09-19 CA CA002500200A patent/CA2500200A1/en not_active Abandoned
- 2003-09-19 PL PL03375046A patent/PL375046A1/xx not_active Application Discontinuation
- 2003-09-19 ES ES03770361T patent/ES2320440T3/es not_active Expired - Lifetime
- 2003-09-19 RU RU2005111964/04A patent/RU2005111964A/ru not_active Application Discontinuation
- 2003-09-19 WO PCT/US2003/029528 patent/WO2004028538A1/en not_active Ceased
- 2003-09-19 BR BR0314802-5A patent/BR0314802A/pt not_active IP Right Cessation
- 2003-09-19 CN CNA038231271A patent/CN1684682A/zh active Pending
- 2003-09-26 TW TW092126679A patent/TW200407158A/zh unknown
-
2006
- 2006-01-20 US US11/336,536 patent/US20060121090A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7071211B2 (en) | 2006-07-04 |
| JP2006503070A (ja) | 2006-01-26 |
| HK1074389A1 (en) | 2005-11-11 |
| CN1684682A (zh) | 2005-10-19 |
| UA81922C2 (uk) | 2008-02-25 |
| US20060121090A1 (en) | 2006-06-08 |
| DE60326051D1 (de) | 2009-03-19 |
| TW200407158A (en) | 2004-05-16 |
| KR20050057581A (ko) | 2005-06-16 |
| WO2004028538A1 (en) | 2004-04-08 |
| CA2500200A1 (en) | 2004-04-08 |
| EP1542687A1 (de) | 2005-06-22 |
| EP1542687B1 (de) | 2009-01-28 |
| RU2005111964A (ru) | 2005-10-10 |
| BR0314802A (pt) | 2005-08-09 |
| ES2320440T3 (es) | 2009-05-22 |
| MXPA05003113A (es) | 2005-06-22 |
| AU2003278842A1 (en) | 2004-04-19 |
| PL375046A1 (en) | 2005-11-14 |
| US20040068017A1 (en) | 2004-04-08 |
| AU2003278842B2 (en) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE421879T1 (de) | Kleine organische moleküle, die die aktivität von gelatinase a in zellen der augen steigern | |
| WO2007002781A3 (en) | Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells | |
| DE69527799D1 (de) | Medikamente zur erhöhung des kammerwasserausflusses bei der glaukombehandlung | |
| BR0314266A (pt) | Dispositivos e métodos para a melhora de visão | |
| CA2585691A1 (en) | Enhanced bimatoprost ophthalmic solution | |
| MY141143A (en) | Contact lenses and methods for reducing conjunctival pressure in contact lens wearers | |
| AU2001280736A1 (en) | Contact lenses with microchannels | |
| CY1108651T1 (el) | Προληπτικος ή θεραπευτικος παραγων για γλαυκωμα | |
| CR8997A (es) | Produccion de polipeptidos | |
| PA8620901A1 (es) | Derivados de prostaglandinas | |
| BRPI0511339A (pt) | revestimentos córneos e correção de aberração de frente de onda para melhorar a visão | |
| ES2140703T3 (es) | Nuevos carbamatos de fenilalquilamino-alcohol y procedimiento para su preparacion. | |
| AR057252A1 (es) | Inhibicion de rho quinasa mediada por arni para el tratamiento de trastornos oculares | |
| BR0312802A (pt) | Pró-drogas de inibidores de bombas de próton | |
| UY29348A1 (es) | Inhibición de objetivos oculares mediada por arni | |
| NO20073739L (no) | Kontaktlinseutforming for storamplitude translasjon | |
| WO2004053069A3 (en) | PROTECTION OF STEM CELLS FROM CYTOTOXIC AGENTS BY MODULATION OF β-CATENIN SIGNALING PATHWAYS | |
| WO2023205618A3 (en) | Ccr4 antagonists | |
| UY29802A1 (es) | Análogos de la feniletilamina y su uso en el tratamiento del glaucoma | |
| WO2006084772A3 (en) | Stabilized ultra-violet absorbers | |
| AR064015A1 (es) | Inhibicion mediada por arni de acuaporina 1 para tratamiento de afecciones relacionadas con pio | |
| CN114939167B (zh) | Integrin/ROCK信号通路靶向调控剂在制备修复细胞骨架损伤修复药物的应用 | |
| ATE412435T1 (de) | Verwendung eines färbemittels zur anfärbung von der augenlinsenkapsel oder von an der netzhaut des auges entstandenen membranen | |
| SI1969159T1 (sl) | Membranski sistem elektrolitskih reaktorjev s štirimi komorami | |
| AR056489A1 (es) | Procesamiento de llamadas en una radio con llamada selectiva y métodos correspondientes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |